LAURA
DE ARMAS RILLO
PROFESOR ACREDITADO
Hospital de Gran Canaria Dr. Negrin
Las Palmas de Gran Canaria, EspañaPublications en collaboration avec des chercheurs de Hospital de Gran Canaria Dr. Negrin (11)
2023
-
Disease activity in patients with rheumatoid arthritis increases serum levels of apolipoprotein C-III
Clinical and experimental rheumatology, Vol. 41, Núm. 1, pp. 67-73
2022
-
Amylin serum levels are upregulated in patients with systemic lupus erythematosus
Clinical and Experimental Rheumatology, Vol. 40, Núm. 7, pp. 1378-1384
-
Apolipoprotein C-III is linked to the insulin resistance and beta-cell dysfunction that are present in rheumatoid arthritis
Arthritis Research and Therapy, Vol. 24, Núm. 1
-
Key Molecules of Triglycerides Pathway Metabolism Are Disturbed in Patients With Systemic Lupus Erythematosus
Frontiers in Immunology, Vol. 13
-
The angiopoietin-like protein 4, apolipoprotein C3, and lipoprotein lipase axis is disrupted in patients with rheumatoid arthritis
Arthritis Research and Therapy, Vol. 24, Núm. 1
2021
-
Differences in Capacity of High-Density Lipoprotein Cholesterol Efflux Between Patients With Systemic Lupus Erythematosus and Rheumatoid Arthritis
Arthritis Care and Research, Vol. 73, Núm. 11, pp. 1590-1596
-
Higher prevalence and degree of insulin resistance in patients with rheumatoid arthritis than in patients with systemic lupus erythematosus
Journal of Rheumatology, Vol. 48, Núm. 3
-
Proprotein convertase subtilisin/kexin type 9 in the dyslipidaemia of patients with axial spondyloarthritis is related to disease activity
Rheumatology (Oxford, England), Vol. 60, Núm. 5, pp. 2296-2306
2020
-
Comparable effects of traditional cardiovascular risk factors on subclinical atherosclerosis in systemic lupus erythematosus and rheumatoid arthritis
Clinical and Experimental Rheumatology, Vol. 38, Núm. 5, pp. 917-924
-
Impaired HDL cholesterol efflux capacity in systemic lupus erythematosus patients is related to subclinical carotid atherosclerosis
Rheumatology (Oxford, England), Vol. 59, Núm. 10, pp. 2847-2856
-
Proprotein convertase subtilisin/kexin type 9 is related to disease activity and damage in patients with systemic erythematosus lupus
Therapeutic Advances in Musculoskeletal Disease, Vol. 12